What is the HCA stock price?

HCA Healthcare, Inc. (HCA) last available close: $469.03, as of 10/23/26. Prices on Cylvex may be delayed.

How many analyst price targets for HCA were reached?

81 of 90 published price targets for HCA were reached within 12 months (90% reached); 16 are still open. Counts only — firm names and target values are shown to signed-in members.

How many firms publish price targets or ratings on HCA?

24 firms have published price targets or ratings on HCA that Cylvex tracks. Counts only — firm names and target values are shown to signed-in members.

Is this investment advice?

No. Cylvex is an educational and informational platform; nothing on this page is investment, financial or trading advice. Past analyst targets do not predict future results.

HCA

HCA Healthcare, Inc. · NYSE

$469.03USDCS band Mixed

↑ $1.72 (0.37%)

Last close · Oct 23, 4:00 PM ET

Mkt Cap

$101.5B

Volume

57.3K

52W High

$556.52

52W Low

$353.99

PE Ratio

14.9

Avg Vol

1.3M

As of 10/23/26

Div Yield

0.67%

Beta

0.16

As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about HCA?

Latest news

News ›

GlobeNewswire Inc.10/19/26

HCA Healthcare Foundation Awards $25,000 to Waypoint to Expand the Network of Adults Supporting Youth Mental Wellness Across Virginia

The HCA Healthcare Foundation awarded a $25,000 grant to Waypoint (formerly Virginia Home for Boys and Girls) to expand its Therapeutic Resources team and support free Youth Mental Health First Aid and Community Resiliency Model trainings across Virginia. The funding, part of HCA Healthcare Foundation's $75 million Healthier Tomorrow Fund, will help train more adults to recognize and respond to youth mental health challenges.

GlobeNewswire Inc.10/13/26

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. – HCA

Pomerantz LLP is investigating potential securities fraud claims on behalf of HCA Healthcare investors following the company's July 14, 2026 announcement of sharply lowered full-year profit guidance due to an unfavorable shift in payer mix that impacted revenue by approximately $400 million in Q2. The news triggered a 6.95% stock price decline.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h

Replies 24h

Watchers

Board · $HCA · 0 threads

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.